Impairment of immunogenicity of Salmonella typhi Ty21a due to pre-existing cross-reacting intestinal antibodies.
Forrest
B D
BD
Communicable Disease Surveillance Centre, Public Health Laboratory Service, London, United Kingdom.
D000284:Administration, Oral; D000328:Adult; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D003429:Cross Reactions; D004306:Dose-Response Relationship, Immunologic; D006801:Humans; D018928:Immunity, Mucosal; D007071:Immunoglobulin A, Secretory / Q000096:biosynthesis; D007413:Intestinal Mucosa / Q000276:immunology*; D007583:Jejunum / Q000276:immunology; D012485:Salmonella typhi / Q000276:immunology*; D014436:Typhoid-Paratyphoid Vaccines / Q000008:administration & dosage / Q000276:immunology*
D000907:Antibodies, Bacterial; D007071:Immunoglobulin A, Secretory; D014436:Typhoid-Paratyphoid Vaccines